Fetal growth restriction: Difference between revisions
Feedback

From WikiLectures

No edit summary
No edit summary
Line 20: Line 20:
* '''Endocrine factors''': VEGF, PlGF, sFlt-1, PAPP-A, [[IGF]].<ref name="Rennie5thChapter10" />
* '''Endocrine factors''': VEGF, PlGF, sFlt-1, PAPP-A, [[IGF]].<ref name="Rennie5thChapter10" />


==Důsledky==
==Consequences==
*'''Perinatální''': úmrtí plodu.
*'''Perinatal''': death of the fetus.
*'''Neonatální''': [[Syndrom dechové tísně (pediatrie)|syndrom dechové tísně (RDS)]], [[srdeční selhání]], [[akutní renální selhání]], [[Hypoglykémie novorozence|hypoglykémie]] (v důsledku snížených zásob glykogenu), hyperglykémie (při nízké produkci inzulinu u velmi nezralých novorozenců), hypotermie (malé tukové zásoby),[[hypoxicko-ischemická encefalopatie]], [[Křeče u novorozence|křeče]] [[Polycytémie (neonatologie)|polycytémie]], [[hyperviskózní syndrom]], [[trombocytopenie]], [[Hyperbilirubinemie novorozenců a kojenců|hyperbilirubinémie]], potravinové intolerance, [[nekrotizující enterokolitida]], [[koagulopatie]], infekční komplikace, [[vrozené vývojové vady]], [[adrenální insuficience]], úmrtí novorozence.
*'''Neonatal''': [[Respiratory distress syndrome (pediatrics)|respiratory distress syndrome (RDS)]], [[Heart failure/Repetitorium|heart failure]], [[acute renal failure]], [[Newborn hypoglycemia|hypoglycemia]] (due to reduced glycogen stores), hyperglycemia (due to low insulin production in very immature newborns), hypothermia (small fat stores), [[hypoxic-ischemic encephalopathy]], [[Convulsions in Pediatrics|convulsions]], [[Polycythemia (neonathology)|polycythemia]], [[hyperviscosity syndrome]], [[thrombocytopenia]], [[Hyperbilirubinemia of newborns and infants|hyperbilirubinemia]], food intolerance, [[necrotizing enterocolitis]], [[coagulopathy]], infectious complications, [[congenital malformations]], [[adrenální insuficience|adrenal insufficiency]], death of a newborn.
*'''Dlouhodobé''': [[bronchopulmonální dysplázie]], opoždění vývoje kognitivních funkcí, [[dětská mozková obrna]].
*'''Long-term''': [[bronchopulmonary dysplasia]], delayed cognitive development, [[Cerebral Palsy in Children|cerebral palsy]].
*'''V dospělosti''': [[Diabetes mellitus 2. typu (endokrinologie)|diabetes mellitus 2. typu]], obezita, hypertenze, [[dyslipidémie]], onemocnění srdce, infarkt, bronchitida, předčasná menopauza.<ref name="Rennie5thChapter10" />
*'''In adulthood''': [[type 2 diabetes mellitus]], obesity, hypertension, [[dyslipidemia]], heart disease, heart attack, bronchitis, premature menopause.<ref name="Rennie5thChapter10" />


==Diagnostika==
==Diagnostics==
Provádí se v 36. týdnu těhotenství.  
It is performed in the 36th week of pregnancy.  


Provedeme biometrii plodu (určení velikosti a hmotnosti). Určíme dopplerovské průtokové parametry, změřením pulzatilního indexu (''a. cerebri media'', ''a. umbilicalis'', ''ductus venosus'' a ''aa. uterinae''). Následně posuzujeme naměřené hodnoty a vytváříme biofyzikální profil plodu. To nám poskytne informace o případných rizicích. A na základě toho můžeme plánovat další postup (včetně předčasného ukončení těhotenství).
We will perform fetal biometrics (size and weight determination). We will determine the Doppler flow parameters by measuring the pulsatile index ( ''a. cerebri media'' , ''a. umbilicalis'' , ''ductus venosus'' and ''aa. uterinae'' ). We then assess the measured values ​​and create a biophysical profile of the fetus. This will give us information about any risks. And based on this, we can plan the next course of action (including early termination of pregnancy).


Pro diagnostiku konkrétní etiologie používáme rozdílná vyšetření (invazivní diagnostika strukturálních abnormalit, sérologie matky pro záchyt teratogenních infekcí, vyloučení strukturálních malformací na UZ apod.).<ref name="Rennie5thChapter10" />
We use different examinations to diagnose a specific etiology (invasive diagnosis of structural abnormalities, maternal serology to detect teratogenic infections, exclusion of structural malformations on ultrasound, etc.).<ref name="Rennie5thChapter10" /><noinclude>
<noinclude>


==Odkazy==
==Links==
===Související články===
===Related articles===
*[[Hypotrofický novorozenec]]
*[[Hypotrophic newborn]]
*[[Novorozenci s nízkou porodní hmotností]]
*[[Low birth weight newborns]]


===Reference===
===Reference===

Revision as of 18:22, 8 April 2023

Fetal growth restriction (FGR) or intrauterine growth restriction/retardation (IUGR ) is a condition where the fetus is unable to reach its genetically determined size (small as a result of a pathological process). The result can be a hypotrophic newborn (weight below the 10th percentile), but also a newborn with a normal birth weight (above the 10th percentile).[1]

The causes can be diverse, the most common arise as a result of pathologies of the placenta. Compared to normally growing individuals, they have increased morbidity and mortality (10 times higher risk of perinatal mortality). There is no cure. We strive for primary prevention of risk factors on the part of the mother (cessation of smoking, regular examinations). The correct timing of childbirth also plays an important role.[2]

Pathophysiology

[[Soubor:Fetal circulation.png|náhled|Krevní oběh plodu]] Centralization of blood circulation occurs during hypoxia. This can cause ischemic damage to the intestine and the development of necrotizing enterocolitis, educed renal flow is often responsible for oligohydramnios, impaired lung growth for chronic lung diseases. Shortening of femur length at the beginning of the second trimester is an early indicator of growth restriction.

Venous return is also affected (flow through the ductus venosus increases during hypoxia). The consequence of this is a decrease in blood flow to the liver, which leads to damage to their functions and a breakdown in glycogen formation (slowing down the growth of the abdominal circumference). Reduced or absent flow in the ductus venosus during atrial systole is a late indicator of cardiac failure leading to intrauterine fetal death.[2]

Risk factors for FGR/IUGR

The physiological growth of the fetus requires an adequate supply of oxygen and nutrients mediated by the placenta. Disruption of placental regulation by endocrine agents can also limit fetal growth and development.

Consequences

Diagnostics

It is performed in the 36th week of pregnancy.

We will perform fetal biometrics (size and weight determination). We will determine the Doppler flow parameters by measuring the pulsatile index ( a. cerebri media , a. umbilicalis , ductus venosus and aa. uterinae ). We then assess the measured values ​​and create a biophysical profile of the fetus. This will give us information about any risks. And based on this, we can plan the next course of action (including early termination of pregnancy).

We use different examinations to diagnose a specific etiology (invasive diagnosis of structural abnormalities, maternal serology to detect teratogenic infections, exclusion of structural malformations on ultrasound, etc.).[2]

Links

Related articles

Reference


Kategorie:Pediatrie Kategorie:Neonatologie Kategorie:Porodnictví